Icarus Medical Raises $7.2M Series A for Orthopedic Bracing

Fundraise Insider tracks newly funded startups each week and delivers verified B2B leads list of C-suite contacts straight to your inbox, so you reach the right people while the funding is still fresh. See pricing.

Icarus Medical, a medical technology company based in Charlottesville, Virginia, has closed a Series A round at $7.2 million. The company had originally set out to raise $5 million, but investor demand pushed the round past that mark and it closed oversubscribed on June 17, 2026.

The round drew a broad group of backers, including Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors.

Icarus builds orthopedic bracing technology designed to help patients stay active, move more easily, and manage pain. Its work pulls together biomechanics, software, and additive manufacturing to produce devices aimed at osteoarthritis, post-operative recovery, neurological conditions, and lower extremity mobility problems. The combination of those three disciplines is what the company points to as the foundation of its product line.

The new capital is set to go toward several fronts at once. The company plans to accelerate commercialization across the US, keep developing its products, expand manufacturing, run clinical validation on current devices, and grow its team as it builds out a larger national presence.

The raise follows a strong stretch for the business. Over the past year, Icarus Medical landed on the Inc. 5000 list of America’s fastest-growing private companies, recording 1,283% growth over three years. It also picked up the 2026 CBIC Startup of the Year Award from the Charlottesville Business Innovation Council, a nod from its home community in central Virginia.

With an oversubscribed round behind it and a clear set of priorities, Icarus Medical is moving into its next stage with the resources to widen both its product range and its reach.